Your search returned 2 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31359368
Year: 2019
Citation:
  • Advances in Therapy. 36(9):2310-2326, 2019 09.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bailey TS, Blonde L, Chao J, Dex TA, Frias JP, Meneghini LF, Roberts M
DOI:
Add to cart
2.
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29246950
Year: 2018
Citation:
  • Diabetes Care. 41(2):258-266, 2018 02.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahmann AJ, Annett MP, Aroda VR, Capehorn M, Charpentier G, Dotta F, Henkel E, Holst AG, Lingvay I
DOI:
Add to cart
Pages

Powered by Koha